Guidelines and Their Rationale: A 2021 Refresher

Access Activity

Overview / Abstract:

Target Audience
This activity is intended for primary care providers, nurse practitioners, physician assistants, certified diabetes educators, nurses, pharmacists, and other care providers involved in the management of people with diabetes.

Learning Objectives
Upon completion of this activity, participants should be able to:

Individualize GLP-1 RA selection based on patient presentation and preference, including needs for glucose reduction, cardiovascular risk, weight, administration route, and frequency (Modules 1, 2, 3 & 5)
Implement the 2021 ADA standard of care pertaining to the use of GLP-1 RAs for reduction of hyperglycemia in people with T2DM (Modules 1 & 5)
Enhance patient understanding of the rationale for selecting a GLP-1 receptor agonist as part of diabetes treatment and share strategies to manage adverse events Modules 1, 2, 3, 4 & 5)

Expiration

Aug 30, 2022

Discipline(s)

Physician CME

Format

Online

Credits / Hours

0.75

Accreditation

ACCME, ACPE, ANCC

Presenters / Authors / Faculty

Jay H. Shubrook, DO
Diana Isaacs, PharmD, BCPS, BCACP, CDCES, FADCES, FCCP
Nicolas Cuttriss, MD, MPH, FAAP

Sponsors / Supporters / Grant Providers

Novo Nordisk, Inc

Keywords / Search Terms

Relias LLC Relias, Free CME, Diabetes Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map